E0 ConsensusModerate confidencePEM not requiredSystematic-ReviewPeer-reviewedMachine draft
Systematic Review and Meta-analysis of Postlicensure Observational Studies on Human Papillomavirus Vaccination and Autoimmune and Other Rare Adverse Events.
Willame, Corinne, Gadroen, Kartini, Bramer, Wichor et al. · The Pediatric infectious disease journal · 2020 · DOI
Quick Summary
Researchers reviewed 22 studies that tracked the safety of HPV vaccines (which prevent certain cancers) in millions of people after the vaccines were approved for use. They looked specifically at whether these vaccines were linked to autoimmune diseases—conditions where the immune system attacks the body. Overall, they found no clear connection between HPV vaccines and most rare diseases, though a few associations (both positive and negative) were noted.
Why It Matters
This review is relevant to ME/CFS patients and researchers because chronic fatigue syndrome was among the rare outcomes specifically assessed in the context of vaccine safety monitoring. Understanding whether vaccines are associated with post-vaccination fatigue syndromes informs both clinical counseling and the development of better surveillance systems for rare adverse events.
Observed Findings
- Forty-three of 48 pooled risk estimates showed no significant association between HPV vaccines and autoimmune/rare diseases.
- Three negative associations were detected: paralysis, immune thrombocytopenia purpura, and chronic fatigue syndrome.
- Two positive associations were detected: Hashimoto disease and Raynaud disease.
- Type 1 diabetes mellitus, immune thrombocytopenia purpura, and thyroiditis were the most frequently reported outcomes across studies.
- Quadrivalent HPV vaccine (4vHPV) was the most commonly assessed vaccine type.
Inferred Conclusions
- HPV vaccines show no clear association with most autoimmune and rare diseases based on current postlicensure surveillance data.
- Systematic collaboration and standardized monitoring protocols are needed to improve detection and characterization of rare safety events.
- The heterogeneity in study methodologies and outcome definitions underscores the need for harmonized surveillance approaches.
Remaining Questions
- Why were negative associations detected for chronic fatigue syndrome and other conditions, and do these represent true protective effects or methodological artifacts?
- How can future postlicensure studies harmonize outcome definitions and study designs to improve the comparability and interpretability of safety estimates?
What This Study Does Not Prove
This study does not prove that HPV vaccines cause or do not cause ME/CFS definitively; it found a negative association in the pooled analysis, but heterogeneous study designs and outcome definitions weaken causal inference. Observational studies cannot exclude unmeasured confounding, and the absence of clear association does not rule out rare or subset-specific effects. The review cannot establish mechanisms or identify which patient populations might be at higher risk.
Tags
Symptom:Fatigue
Phenotype:Infection-Triggered
Method Flag:Mixed Cohort
Metadata
- DOI
- 10.1097/INF.0000000000002569
- PMID
- 31876615
- Review status
- Machine draft
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →